Global Biomaterials market, which was estimated at approximately 100 (USD Billion) in 2019 and is predicted to accrue earnings worth nearly 260 (USD Billion) by 2026, is set to record a CAGR of nearly 15.4% over 2020-2026.
The global Biomaterials market, which was estimated at approximately 100 (USD Billion) in 2019 and is predicted to accrue earnings worth nearly 260 (USD Billion) by 2026, is set to record a CAGR of nearly 15.4% over 2020-2026. The report offers valuation and analysis of Biomaterials market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on value (USD Billion).
The biomaterial is a synthetic or naturally extracted substance utilized in medical fraternity for enhancing the functions of damaged organs & tissues. These substances are utilized for interacting with biological tools for medical purpose. They are also used in medical treatment of orthopedic, heart, neurological, and dental ailments. It is also utilized in tissue engineering, drug delivery equipment, medical implant, and plastic surgery. In addition to this, launching of new bio-materials like ceramic polymeric, natural, and metallic bio-materials will pave a way for the expansion of the biomaterials industry over the forecast timeline.
A rise in the use of biomaterials in biomed engineering research activities as well as bio-mineralization will prompt the business growth. In addition to this, bio-materials are utilized massively in bio-molecule development and this will create lucrative growth avenues for the industry over the forecasting timespan. Apart from this, a surge in the awareness pertaining to benefits accrued due to use of biomaterials will propel the business space over the estimated timeline. Nonetheless, huge biomaterial production costs and side-effects observed due to use of bio-materials will put brakes on the growth of biomaterials industry over the forecast timespan.
Furthermore, it is also utilized during vascular surgeries for preventing blood clotting. Apparently, utilization of the product in drug delivery systems will generate humungous growth prospects for biomaterials industry over the forthcoming years. In addition to this, the product finds massive penetration in dental, orthopedic, neurology, and would healing activities, thereby further driving market trends.
The expansion of the business in the sub-continent over the assessment timespan is due to massive rise in the geriatric populace prone to heart disorders as well as other chronic ailments. In addition to this, rise in the use of the product in plastic surgery, wound healing, and neurology will inflate the market proceeds over the forecast timeline. Surge in the funding made by the government in bio-material production in the countries like Canada and the U.S. will steer the regional market size over the projected timeline.
Key participants leveraging the industry growth are Berkeley Advanced Biomaterials, AdvanSource Biomaterials, DePuy Orthopaedics, Collagen Matrix, Invibio, Angiotech Pharmaceuticals, Dentsply International, Zimmer Biomet, Orthovita, Cam Bioceramics, and Wright Medical Group.
FrequentlyAsked Questions
Rise in the use of biomaterials in biomed engineering research activities as well as bio-mineralization will prompt the business growth. In addition to this, bio-materials are utilized massively in bio-molecule development and this will create lucrative growth avenues for the industry over the forecasting timespan. Apart from this, surge in the awareness pertaining to benefits accrued due to use of biomaterials will propel the business space over the estimated timeline. Nonetheless, huge biomaterial production costs and side-effects observed due to use of bio-materials will put brakes on the growth of biomaterials industry over the forecast timespan.
According to Zion market research report, the global Biomaterials market, which was estimated at approximately 100 (USD Billion) in 2019 and is predicted to accrue earnings worth nearly 260 (USD Billion) by 2026, is set to record a CAGR of nearly 15.4% over 2020-2026.
North America is likely to make noteworthy contributions towards overall market revenue. The regional market growth over 2020-2026 can be credited to massive rise in the geriatric populace prone to heart disorders as well as other chronic ailments. In addition to this, rise in the use of the product in plastic surgery, wound healing, and neurology will inflate the market proceeds over the forecast timeline. Surge in the funding made by the government in bio-material production in the countries like Canada and the U.S. will steer the regional market size over the projected timeline.
The key players profiled in the report include DePuy Orthopaedics, Invibio, Dentsply International, Orthovita, Cam Bioceramics, Zimmer Biomet, Angiotech Pharmaceuticals, AdvanSource Biomaterials, Berkeley Advanced Biomaterials, Collagen Matrix, and Wright Medical Group.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed